Apheresis Equipment Market

Market Insights

The rising incidence of hematological disorders has led to an increase in demand for platelets and plasma products for efficient treatment and an improvement in survival rates. The apheresis equipment market is expected to be driven by growth in the incidence of blood disorders and technological innovations in the nature and efficiency of apheresis equipment. Researchers, healthcare practitioners, and device manufacturers worldwide are therefore introducing solutions that demand minimal human intervention and allow agility to the apheresis process.

For the purpose of this study, the global apheresis equipment market was studied for product type, application, technology, procedure type, and geographical distribution. Based on product types, this market is categorized into apheresis device and disposable kit segments. Membrane filtration and centrifugation are the two technologies adopted for performing apheresis. Apheresis finds major adoption in renal, neurology, hematology, and other such applications.

Based on procedure types, the global apheresis market is segmented into major procedures, namely, plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photopheresis, erythrocytapheresis, and others. Market size and forecast for each of these segments for the period 2013–2023, along with their respective CAGRs for the period 2016–2023, are provided in this study while analyzing the major market developments, commercial events, product positioning, and player movements.

Geographically, the global apheresis equipment market is studied for the following regional markets:

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global apheresis equipment market. Tools such as market positioning of key players, Porter’s five forces analysis, and attractive investment propositions provide the reader with insights into the competitive scenario of the global apheresis equipment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the development, manufacture, and sales of apheresis equipment.

Based on procedure types, the apheresis equipment market is segmented into:

1. Plasmapheresis
2. LDL-apheresis
3. Plateletpheresis
4. Leukapheresis
5. Photopheresis
6. Erythrocytapheresis
7. Others

Plasmapheresis accounts for the largest share of the apheresis equipment market. This procedure is used to segregate plasma from other blood cells. Growing demand for plasma products is the most significant driver for the progress of the plasmapheresis market. Plasmapheresis was first developed by Grifols in 1951. Bleeding and clotting disorders, cardiovascular diseases, and burn injuries are the chief application areas of plasmapheresis. Drugs based on plasma products are also administered to patients with a compromised or weak immune system. The growing incidence of hematological disorders is perpetually growing, thus giving rise to a demand for plasma products and acting as a primary growth driver.

Extracorporeal photopheresis, or photopheresis, is a form of leukapheresis with an additional stage of photo treatment. Photopheresis is approved by the FDA for the treatment of cutaneous T-cell lymphoma and is also used for treating solid organ transplant rejection, type 1 diabetes, scleroderma, lichen planus, atopic dermatitis, and pemphigus Vulgaris. On the basis of the growing prevalence of these diseases, the demand for both open and closed photopheresis systems is on the rise, and this growth will be witnessed throughout the forecast period.

Based on the type of products, the global apheresis equipment market is segmented as follows:

• Apheresis Devices
• Apheresis Disposable Kits
• Moreover, membrane filtration and centrifugation are the two technologies used for performing the apheresis procedure.

Apheresis disposable kits are the largest segment in the total apheresis equipment market. High purchase rates of disposable kits due to high usage volumes, coupled with the ever-growing demand for apheresis procedures, drive the growth of this segment. Filters, tubes, and other such products constitute the assembly of disposable kits. In order to curb the risk of infection, single-use products are in high demand, where single-cycle procedures consume multiple disposable parts.

Such intensive consumption of disposables is responsible for the larger revenue and volume share of the disposable kit segment. The currently available apheresis devices include collection systems, separator units, data management systems, and others. Modern apheresis machines allow for quick turnaround and safety from infections. The demand for apheresis devices is burgeoning in emerging markets such as Asia Pacific and Latin America due to the rapid development of healthcare infrastructure and the growing demand for apheresis procedures.Apheresis procedures find major applications in hematology, renal, neurology, and other treatment areas.

Neurology is the largest segment for apheresis equipment. The increasing prevalence of neurological diseases such as myasthenia gravis and multiple sclerosis is a chief factor contributing to the dominance of this segment. Perpetual widening of the application of apheresis and growth in R&D efforts aimed at introducing novel products in the market will further boost the market growth. Therapeutic plasma exchange is a crucial treatment for treating myasthenia gravis, Guillain-Barre syndrome, multiple sclerosis, or chronic inflammatory demyelinating polyneuropathy.

The increasing prevalence of such diseases and the proven efficiency of apheresis in treating such conditions are major drivers of this application segment. The burden of sickle cell disease is phenomenally high. Red blood cell transfusion is used as an ideal treatment for sickle cell disease, which is a sub-type of therapeutic hemapheresis. Therapeutic plasma exchange, leukapheresis, photopheresis, and plateletpheresis are also becoming popular for treating hematological diseases.

For the purpose of this study, the global apheresis equipment market is categorized as follows:

• North America (U.S. and Canada)
• Europe (Germany, U.K., and the Rest of Europe)
• Asia Pacific (Japan, China, and the Rest of Asia Pacific)
• Latin America (LATAM)
• Middle East and Africa (MEA)

North America held over 45% of the global apheresis equipment market in 2015. Well-developed healthcare infrastructure, high awareness among patients and caregivers, and favorable reimbursement are the key drivers of this market. Centrifugation apheresis technology is anticipated to be in high demand in the North American market during the forecast period. The increasing incidence of hematological and neurological disorders in Europe that demand an apheresis procedure for treatment will drive the European apheresis equipment market.

Additionally, Asia-Pacific is anticipated to be the fastest-growing market for apheresis equipment during the forecast period. The increasing prevalence of blood disorders that demand treatment with platelets and plasma products in emerging markets such as China, Japan, Australia, Korea, and India is a key market driver in the Asia-Pacific market. The rapid development of healthcare infrastructure and improving awareness in the general population will additionally contribute to the demand for apheresis and hence apheresis equipment in the region.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Portraiture: Apheresis Equipment Market
2.2 Global Apheresis Equipment Market, by Products and Technology, 2015 (USD Mn)
2.3 Global Apheresis Equipment Market Share, by Procedure Type, 2015 (Value %)
2.4 Global Apheresis Equipment Market, by Applications, 2015 (USD Mn)
2.5 Global Apheresis Equipment Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Apheresis Equipment Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Porter’s Five Forces Model
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Apheresis Equipment Market, by Key Players

Chapter 4 Global Apheresis Equipment Market, By Products, 2013-2023 (USD Mn)
4.1 Introduction
4.2 Apheresis Devices
4.3 Disposable Kits

Chapter 5 Global Apheresis Equipment Market, By Technology, 2013-2023 (USD Mn)
5.1 Introduction
5.2 Membrane Filtration
5.3 Centrifugation

Chapter 6 Global Apheresis Equipment Market, By Procedure Type, 2013-2023 (USD Mn)
6.1 Introduction
6.2 Plasmapheresis
6.3 LDL-apheresis
6.4 Plateletpheresis
6.5 Leukapheresis
6.6 Photophereis
6.7 Erythrocytapheresis
6.8 Others

Chapter 7 Global Apheresis Equipment Market, By Applications, 2013-2023 (USD Mn)
7.1 Introduction
7.2 Renal
7.3 Neurology
7.4 Hematology
7.5 Others

Chapter 8 Global Apheresis Equipment Market, By Geography, 2013-2023 (USD Mn)
8.1 Preface
8.2 North America (U.S. & Canada)
8.3 Europe (U.K., Germany & Rest of Europe)
8.4 Asia Pacific (Japan, China & Rest of Asia Pacific)
8.5 Latin America
8.6 Middle East and Africa

Chapter 9 Company Profiles
9.1 Haemonetics Corporation
9.2 Terumo BCT, Inc.
9.3 HemaCare Corporation
9.4 Asahi Kasei Kuraray Medical Co., Ltd.
9.5 Fenwal, Inc.
9.6 B Braun Melsungen AG
9.7 Medica SpA
9.8 Feresenius Kabi
9.9 Cerus Corporation
9.10 Kawasumi Laboratories Inc.
9.11 Kaneka Corporation
9.12 Nikkiso Co., Ltd.
9.13 Therakos, Inc.
9.14 Other Notable Players

List of Figures

FIG. 1 Apheresis Equipment Market: Research Methodology
FIG. 2 Global Apheresis Equipment Market, by Products and Technology, 2015 (USD Mn)
FIG. 3 Global Apheresis Equipment Market Share, by Procedure Type, 2015 (Value %)
FIG. 4 Global Apheresis Equipment Market, by Applications, 2015 (USD Mn)
FIG. 5 Global Apheresis Equipment Market Share, by Geography, 2015 (Value %)
FIG. 6 Porter’s Five Forces Model: Global Apheresis Equipment Market
FIG. 7 Attractive Investment Proposition, by Geography
FIG. 8 Market Positioning of Apheresis Equipment Manufacturers, 2015
FIG. 9 Global Apheresis Devices Market, 2013–2023 (USD Mn)
FIG. 10 Global Apheresis Disposable Kits Market, 2013–2023 (USD Mn)
FIG. 11 Global Membrane Filtration Apheresis Market, 2013–2023 (USD Mn)
FIG. 12 Global Centrifugation Apheresis Market, 2013 – 2023 (USD Mn)
FIG. 13 Global Plasmapheresis Equipment, 2013–2023 (USD Mn)
FIG. 14 Global LDL-apheresis Equipment Market, 2013 – 2023 (USD Mn)
FIG. 15 Global Plateletpheresis Equipment Market, 2013 – 2023 (USD Mn)
FIG. 16 Global Leukapheresis Equipment Market, 2013 – 2023 (USD Mn)
FIG. 17 Global PhotophereisEquipment Market, 2013 – 2023 (USD Mn)
FIG. 18 Global Erythrocytapheresis Equipment Market, 2013 – 2023 (USD Mn)
FIG. 19 Global Apheresis Equipment Market for Other Procedures, 2013 – 2023 (USD Mn)
FIG. 20 Global Apheresis Equipment Market for Renal Applications, 2013–2023 (USD Mn)
FIG. 21 Global Apheresis Equipment Market for Neurology Applications, 2013–2023 (USD Mn)
FIG. 22 Global Apheresis Equipment Market for Hematology Applications, 2013–2023 (USD Mn)
FIG. 23 Global Apheresis Equipment Market for Other Applications, 2013–2023 (USD Mn)

List of Tables

TABLE 1 Global Apheresis Equipment Market, By Products, 2013-2023 (USD Mn)
TABLE 2 Global Apheresis Equipment Market, By Technology, 2013-2023 (USD Mn)
TABLE 3 Global Apheresis Equipment Market, By Procedure Type, 2013-2023 (USD Mn)
TABLE 4 Global Apheresis Equipment Market, By Applications, 2013-2023 (USD Mn)
TABLE 5 Global Apheresis Equipment Market, by Geography, 2013–2023 (USD Mn)
TABLE 6 North America Apheresis Equipment Market, by Country, 2013–2023 (USD Mn)
TABLE 7 Europe Apheresis Equipment Market, by Country, 2013–2023 (USD Mn)
TABLE 8 Asia Pacific Apheresis Equipment Market, by Country, 2013–2023 (USD Mn)
TABLE 9 Latin America Apheresis Equipment Market, by Type, 2013–2023 (USD Mn)
TABLE 10 Middle East and Africa Apheresis Equipment Market, by Type, 2013–2023 (USD Mn)
TABLE 11 Haemonetics Corporation: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 12 Terumo BCT, Inc.: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 13 HemaCare Corporation: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 14 Asahi Kasei Kuraray Medical Co., Ltd. Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 15 Fenwal, Inc.: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 16 B Braun Melsungen AG: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 17 Medica SpA: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 18 Feresenius Kabi: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 19 Cerus Corporation: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 20 Kawasumi Laboratories Inc.: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 21 Kaneka Corporation: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 22 Nikkiso Co., Ltd.: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage)
TABLE 23 Therakos, Inc.: Company Snapshot (Business Description, Financial Health and Business Allocation, Product Position and Portfolio, News Coverage).